How is the Rapport Therapeutics Inc. today?

The Rapport Therapeutics Inc. today is trading in the down by -5.25% at 11.73.

What is Rapport Therapeutics Inc. Annual Net Profit?

Rapport Therapeutics Inc. Annual Net Profit fell 125.11% in the last year to $78.31 M. Its sector's average net profit growth for the last fiscal year was -28.42%.

What is Rapport Therapeutics Inc. Price to Earning Ratio?

Rapport Therapeutics Inc. Price to Earning Ratio is -5.37, which is negative.

What is Rapport Therapeutics Inc. Stock Price?

Rapport Therapeutics Inc. Stock Price rose 7.12% outperformed its sector by 2.8% in the past week.

What is Rapport Therapeutics Inc. Quarterly Net profit?

Rapport Therapeutics Inc. Quarterly Net profit fell 6.15% YoY to $24.06 M. Its sector's average net profit growth YoY for the quarter was -20.03%.

What is Rapport Therapeutics Inc. Debt to Equity Ratio?

Rapport Therapeutics Inc. Debt to Equity Ratio is zero as the company is debt-free.

What is Rapport Therapeutics Inc. Return on Equity(ROE)?

Rapport Therapeutics Inc. Return on Equity(ROE) for the last financial year was -55.98%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Rapport Therapeutics Inc. Mutual Fund Holding?

Rapport Therapeutics Inc. Mutual Fund Holding increased by 0.05% in the last quarter to 39.88.

What is Rapport Therapeutics Inc. Institutional Holding?

Rapport Therapeutics Inc. Institutional Holding remained the same in the last quarter at 104.5%.

Rapport Therapeutics Inc. XNAS: RAPP

Rapport Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Rapport Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Rapport Therapeutics Inc.
Rating: 1.31691675
Author: Trendlyne DVM scores

about

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucid...

11.73 -0.65 (-5.25%)

60.56% Fall from 52W High

126.5K

XNAS Volume

XNAS 25 Jun, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

11.7 / 100

Technically Neutral

41.0 / 100

No estimates available

Rapport Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Rapport Therapeutics Inc. FAQ

How is Rapport Therapeutics Inc. today?

Rapport Therapeutics Inc. today is trading in the red, and is down by -5.25% at 11.73.

How has Rapport Therapeutics Inc. performed historically?

Rapport Therapeutics Inc. is currently trading down -5.25% on an intraday basis. In the past week the stock rose 7.12%. stock has been up 14.77% in the past quarter and fell None% in the past year. You can view this in the overview section.